Thomas D. Reed, Chief Science Officer at INTREXON CORP (XON), sold 227,800 shares at $4.22 ($954K) on 2019-03-04, disclosed to the SEC on 2019-03-06.
Open-market sale of $954k XON by Chief Science Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.17 | 165,000 | $688K | 72.1% |
| 2 | $4.22 | 44,000 | $186K | 19.5% |
| 3 | $4.24 | 16,500 | $70K | 7.3% |
| 4 | $4.66 | 2,300 | $11K | 1.1% |
| Total | $4.19 avg | 227,800 | $954K | 100% |
| Filing → |
| XON | SELL | 2020-01-03 | $20K | — | Filing → |
| XON | SELL | 2019-10-02 | $20K | — | Filing → |
| XON | SELL | 2019-07-02 | $27K | — | Filing → |